Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type
Crossref DOI link: https://doi.org/10.1007/s00592-016-0897-2
Published Online: 2016-09-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ross, P
Gray, AR
Milburn, J
Kumarasamy, IM
Wu, F
Farrand, S
Armishaw, J
Wiltshire, E
Rayns, J
Tomlinson, P
Wheeler, BJ
Funding for this research was provided by:
Otago Medical Research Foundation
University of Otago
License valid from 2016-09-01